AAAAAA
Results: 1-25/44
Authors:
HURLEN M
SELJEFLOT I
ARNESEN H
Citation: M. Hurlen et al., THE EFFECT OF DIFFERENT ANTITHROMBOTIC REGIMENS ON PLATELET-AGGREGATION AFTER MYOCARDIAL-INFARCTION, SC CARDIOVA, 32(4), 1998, pp. 233-237
Authors:
JOHANSEN O
BREKKE M
STROMME JH
VALEN V
SELJEFLOT I
SKJAEGGESTAD O
ARNESEN H
Citation: O. Johansen et al., MYOCARDIAL DAMAGE DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AS EVIDENCED BY TROPONIN-T MEASUREMENTS, European heart journal, 19(1), 1998, pp. 112-117
EFFECTS OF DOXAZOSIN AND ATENOLOL ON ATHEROTHROMBOGENIC RISK PROFILE IN HYPERTENSIVE MIDDLE-AGED MEN
Authors:
ANDERSEN P
SELJEFLOT I
HERZOG A
ARNESEN H
HJERMANN I
HOLME I
Citation: P. Andersen et al., EFFECTS OF DOXAZOSIN AND ATENOLOL ON ATHEROTHROMBOGENIC RISK PROFILE IN HYPERTENSIVE MIDDLE-AGED MEN, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 677-683
Authors:
SELJEFLOT I
MOAN A
ASPELIN T
TONNESSEN T
KJELDSEN SE
ARNESEN H
Citation: I. Seljeflot et al., CIRCULATING LEVELS OF ENDOTHELIN-1 DURING ACUTE HYPERINSULINEMIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION TREATED WITH TYPE-1 ANGIOTENSIN RECEPTOR ANTAGONIST OR PLACEBO, Metabolism, clinical and experimental, 47(3), 1998, pp. 292-296
Authors:
SELJEFLOT I
ARNESEN H
BRUDE IR
NENSETER MS
DREVON CA
HJERMANN I
Citation: I. Seljeflot et al., EFFECTS OF OMEGA-3-FATTY-ACIDS AND OR ANTIOXIDANTS ON ENDOTHELIAL-CELL MARKERS/, European journal of clinical investigation, 28(8), 1998, pp. 629-635
Authors:
OS I
SELJEFLOT I
HOFSTAD A
DJUROVIC S
ARNESEN H
Citation: I. Os et al., HORMONE REPLACEMENT THERAPY IN WOMEN WITH CORONARY-ARTERY DISEASE REDUCES ENDOTHELIAL-CELL MARKERS - THE EWA STUDY, Circulation, 98(17), 1998, pp. 3467-3467
Authors:
MULLER H
JORDAL O
SELJEFLOT I
KIERULF P
KIRKHUS E
LEDSAAK O
PEDERSEN JI
Citation: H. Muller et al., EFFECT ON PLASMA-LIPIDS AND LIPOPROTEINS OF REPLACING PARTIALLY HYDROGENATED FISH-OIL WITH VEGETABLE FAT IN MARGARINE, British Journal of Nutrition, 80(3), 1998, pp. 243-251
Authors:
BRUDE IR
DREVON CA
HJERMANN I
SELJEFLOT I
LUNDKATZ S
SAAREM K
SANDSTAD B
SOLVOLL K
HALVORSEN B
ARNESEN H
NENSETER MS
Citation: Ir. Brude et al., PEROXIDATION OF LDL FROM COMBINED-HYPERLIPIDEMIC MALE SMOKERS SUPPLIED WITH (OMEGA)OVER-BAR-3 FATTY-ACIDS AND ANTIOXIDANTS, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2576-2588
Authors:
SELJEFLOT I
JOHANSEN O
EGGESBO JB
KIERULF P
ARNESEN H
Citation: I. Seljeflot et al., DECREASED PROCOAGULANT ACTIVITY AND IMPAIRED CYTOKINE EXPRESSION IN WHOLE-BLOOD CULTURES FROM PATIENTS WITH CORONARY HEART-DISEASE SUPPLEMENTED WITH N-3 FATTY-ACID, Thrombosis and haemostasis, 1997, pp. 464-464
Authors:
AMESEN H
SELJEFLOT I
SANDSET PM
HJERMANN I
PEDERSEN T
Citation: H. Amesen et al., CHANGES IN SOLUBLE ENDOTHELIAL-CELL MARKERS DURING TREATMENT WITH SIMVASTATIN OR PLACEBO IN PATIENTS WITH CORONARY HEART-DISEASE, Thrombosis and haemostasis, 1997, pp. 558-558
Authors:
ARNESEN H
DAHL OE
ASPELIN T
SELJEFLOT I
Citation: H. Arnesen et al., PREDICTIVITY OF SERUM D-DIMER, A GLOBAL TEST OF FIBRINOLYSIS AN DEEP VENOUS THROMBOSIS AFTER HIP-REPLACEMENT SURGERY, Thrombosis and haemostasis, 1997, pp. 653-653
Authors:
SELJEFLOT I
AMESEN H
HJERMANN I
BRUDE I
NENSETER M
DREVON C
Citation: I. Seljeflot et al., EFFECT OF SUPPLEMENTATION WITH N-3 FATTY-ACIDS AND OR ANTIOXIDANTS ONCIRCULATING MARKERS OF VASCULAR ENDOTHELIAL FUNCTION IN MALE HYPERLIPIDEMIC SMOKERS/, Thrombosis and haemostasis, 1997, pp. 2781-2781
Authors:
HAGBERG IA
HURLEN M
SELJEFLOT I
AMESEN H
LYBERG T
Citation: Ia. Hagberg et al., PLATELET-LEUKOCYTE ADHESION - A STUDY OF ASPIRIN VS WARFARIN TREATMENT IN STABLE PHASE AFTER AMI, Thrombosis and haemostasis, 1997, pp. 2789-2789
Authors:
BRUDE IR
DREVON CA
HJERMAN I
SELJEFLOT I
NENSETER MS
Citation: Ir. Brude et al., PEROXIDATION OF LOW-DENSITY-LIPOPROTEIN FROM MALE HYPERLIPIDEMIC SMOKERS SUPPLIED WITH OMEGA-3-FATTY-ACIDS AND ANTIOXIDANTS, Atherosclerosis, 134(1-2), 1997, pp. 220-220
Authors:
ALMENDINGEN K
SELJEFLOT I
SANDSTAD B
PEDERSEN JI
Citation: K. Almendingen et al., EFFECTS OF PARTIALLY HYDROGENATED FISH-OIL, PARTIALLY HYDROGENATED SOYBEAN OIL, AND BUTTER ON HEMOSTATIC VARIABLES IN MEN, Arteriosclerosis, thrombosis, and vascular biology, 16(3), 1996, pp. 375-380
Authors:
MOAN A
HOIEGGEN A
SELJEFLOT I
RISANGER T
ARNESEN H
KJELDSEN SE
Citation: A. Moan et al., THE EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONISM WITH LOSARTAN ON GLUCOSE-METABOLISM AND INSULIN SENSITIVITY, Journal of hypertension, 14(9), 1996, pp. 1093-1097
Authors:
SELJEFLOT I
MOAN A
KJELDSEN S
SANDVIK E
ARNESEN H
Citation: I. Seljeflot et al., EFFECT OF ANGIOTENSIN-II RECEPTOR BLOCKADE ON FIBRINOLYSIS DURING ACUTE HYPERINSULINEMIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Hypertension, 27(6), 1996, pp. 1299-1304
Authors:
SELJEFLOT I
MOAN A
TONNESSEN T
KJELDSEN SE
ARNESEN H
Citation: I. Seljeflot et al., EFFECTS OF HYPERINSULINEMIA AND ANGIOTENSIN-II RECEPTOR BLOCKAGE ON PLASMA ENDOTHELIN-1 IN PATIENTS WITH HYPERTENSION, Circulation, 94(8), 1996, pp. 1988-1988
Authors:
ERITSLAND J
ARNESEN H
SELJEFLOT I
KIERULF P
Citation: J. Eritsland et al., LONG-TERM EFFECTS OF N-3 POLYUNSATURATED FATTY-ACIDS ON HEMOSTATIC VARIABLES AND BLEEDING EPISODES IN PATIENTS WITH CORONARY-ARTERY DISEASE, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 17-22
Authors:
SELJEFLOT I
JOHANSEN O
ARNESEN H
Citation: I. Seljeflot et al., EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY-ACIDS (PUFA) ON VASCULAR ENDOTHELIAL-CELL MARKERS, Thrombosis and haemostasis, 73(6), 1995, pp. 908-908
Authors:
DAHL OE
ASPELIN T
LYBERG T
SELJEFLOT I
KIERULF P
RUYTER R
ARNESEN H
Citation: Oe. Dahl et al., LOW INITIAL PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-I) RESPONSE ASSOCIATED WITH LATE DEEP VENOUS THROMBOSIS (DVT) AFTER HIP-REPLACEMENT SURGERY (HRS), Thrombosis and haemostasis, 73(6), 1995, pp. 1005-1005
Authors:
ERITSLAND J
GJONNES G
SANDSET PM
SELJEFLOT I
ARNESEN H
Citation: J. Eritsland et al., ACTIVATED PROTEIN-C RESISTANCE - PREVALENCE AMONG PATIENTS UNDERGOINGCORONARY-ARTERY BYPASS-SURGERY AND RELATION TO SHUNT OCCLUSIONS, Thrombosis and haemostasis, 73(6), 1995, pp. 1374-1374
Authors:
ERITSLAND J
ARNESEN H
SELJEFLOT I
Citation: J. Eritsland et al., DOES LONG-TERM WARFARIN THERAPY ADVERSELY AFFECT THE ATHEROGENIC LIPID PROFILE IN PATIENTS WITH CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1390-1390
Authors:
SELJEFLOT I
ARNESEN H
STOEN R
LYBERG T
Citation: I. Seljeflot et al., EFFECTS OF INSULIN AND SOME VASOCONSTRICTORS ON THE SYNTHESIS AND RELEASE OF T-PA AND PAI-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS, Fibrinolysis, 9(4), 1995, pp. 253-257
Authors:
DAHL OE
ASPELIN T
ARNESEN H
SELJEFLOT I
KIERULF P
RUYTER R
LYBERG T
Citation: Oe. Dahl et al., INCREASED ACTIVATION OF COAGULATION AND FORMATION OF LATE DEEP VENOUSTHROMBOSIS FOLLOWING DISCONTINUATION OF THROMBOPROPHYLAXIS AFTER HIP-REPLACEMENT SURGERY, Thrombosis research, 80(4), 1995, pp. 299-306